Zhengye biotechnology holding limited announces pricing of initial public offering

Jilin, china, jan. 06, 2025 (globe newswire) -- zhengye biotechnology holding limited (the "company" or "zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccine in china, today announced the pricing of its initial public offering (the "offering") of 1,500,000 ordinary shares at a public offering price of us$4.00 per ordinary share. the ordinary shares have been approved for listing on the nasdaq capital market and are expected to commence trading on january 7, 2025 under the ticker symbol "zybt." the offering is expected to close on or about january 8, 2025, subject to the satisfaction of customary closing conditions.
ZYBT Ratings Summary
ZYBT Quant Ranking